Regulators expect brokerage firms to maintain controls designed to prevent the firm from submitting orders to market centers that create a risk of disruptive trading (e.g., the risk of sudden, transient price moves).
To comply with these expectations, Interactive Brokers implements various price filters on customer orders. Those price filters may, in certain circumstances, price cap customer orders in order to avoid market disruption, and those Price Caps will generally be in a % range from a reference price range calculated by IB. (The range of the Price Cap varies depending on the type of instrument and the current price.)
Although the price caps are intended to balance the objectives of trade certainty and minimized price risk, a trade may be delayed or may not take place as a result of price capping. More information is available in Interactive Broker’s Order Routing and Payment for Order Flow Disclosure.
If a customer’s order(s) are price capped by IB’s systems, that customer will either receive (i) real-time notification of those price cap(s) in Trader Workstation or via the API or FIX tag 58 (for FIX users); and/or (ii) a daily FYI message containing a digest of the first 10 order(s) that were price capped the prior day, the initial price cap(s) for those order(s) (if applicable), and the Price Cap Range(s) for further Price Cap(s) of those order(s).
Customers may opt out from receiving future FYI Messages by clicking the relevant opt-out link within an FYI Message. By opting out from receiving these future FYI Messages, a customer:
Trading fractional shares allows you to invest in companies which you may not be able to afford the full share price. It also makes it easier for you to diversify your portfolio by allowing you to purchase fractional amounts in multiple companies when you otherwise may have only been able to purchase whole shares in one or two companies.
If you enable your account to trade in fractions, we will buy or sell a fraction of a share based on the amount of cash you specify. For example, if you want to spend $500 but one share of the stock you want to buy is currently $1000 you would end up with 0.5 shares.
Who is eligible for fractional share permissions?
All individual, standalone accounts (except those who reside in Israel, Canadian RRSP/TFSA accounts and Interactive Brokers Securities Japan Inc. ("IBSJ") entity accounts) are eligible for fractional share permissions.
Financial Advisors, Money Managers, and Introducing Brokers may enable their clients on an all-or-none basis.
How do I enable fractional shares?
If you are eligible then you can enable fractional share trading in Client Portal. Click the User menu (head and shoulders icon in the top right corner) followed by Settings. Under Account Settings find the section Trading and click on Trading Permissions. Scroll to "Stocks", click +Add and check the box next to "Global (Trade in Fractions)" and click on SAVE. Then click CONTINUE and follow the prompts on screen. You will then be able to trade in fractions in eligible stocks for which you have permission to trade. To trade fractions of eligible U.S. stocks, you will need to sign up to trade U.S. stocks, and to trade fractions of eligible European stocks, you will need to sign up to trade European stocks.
Please note, TWS Build Version 979 or later is required to trade fractional shares. This feature currently supports most order types.
What products can I trade in fractions?
We offer fractional share trading on eligible U.S., Canadian and European stocks and ETFs*.
A list of eligible stocks that can be traded in fractional shares is available via the following link. Please note, this list is subject to change without notice:
http://www.ibkr.com/download/fracshare_stk.csv
*Under EU regulations, EU retail clients generally cannot trade U.S. ETFs, in whole or fractional increments.
Can I short fractional shares?
IBKR does support short sales in fractional shares of eligible stocks as long as you have margin and approved trading permissions to trade fractional shares of stocks listed in the U.S. or in Europe.
What are the fees associated with fractional shares?
There is no additional fee to use fractional share trading. Standard commission rates (both IBKR Lite and IBKR Pro, where applicable) apply.
What order types can I choose for fractional trading?
IBKR will only accept certain types of orders for fractional shares (e.g., market orders, limit orders, stop orders, stop limit orders, etc.). If you choose to place an unmarketable limit order with a fractional share component, the fractional component may not execute until the order becomes marketable (and therefore may not execute at all), even if the order might have executed earlier if submitted for a whole share quantity.
How does IBKR handle fractional shares orders in European stocks?
Depending on the size and nature of the order, IBKR will direct orders in European stocks that include a fractional share component to a pool of execution venues which might be different than those utilized for other order types. You should review the applicable order execution policy for more details.
Can I transfer fractional shares to IBKR?
IBKR does not accept fractional shares through a position transfer.
Are fractional shares eligible for the Dividend Reinvestment Program (DRIP)?
Yes, it is possible to receive fractional shares for a reinvested dividend through the Dividend Reinvestment Program (DRIP) if the account has fractional share permissions.
Please note the above does not apply in the event of mutual fund dividends, which can be re-invested and may result in holding fractional shares of the fund.
Will I receive a fractional share position from a corporate action?
If your account has been approved for trading fractions and a US or European corporate action issues fractional shares, the fractional shares will remain in your account. However, if your account does not have permissions to trade in fractions or the corporate action is issuing non-eligible shares, the fractional shares will be liquidated.
Will I have voting rights for fractional shares in my account?
You will not have voting rights for any of the fractional shares held in your account, you will not be able to make voluntary elections on any corporate action (including, without limitation, any tender offers or rights offerings) with respect to such fractional shares, and we cannot provide you any other shareholder documentation for any holdings of less than one share.
Do I receive dividends on my fractional shares?
Your fractional shares positions are eligible to receive dividends in the same manner as your full positions on the same stocks.
Is fractional trading available for the API?
Fractional trading is supported via FIX/CTCI but not via API at this time.
背景
2018年,一項歐盟新規生效,該新規旨在對“零售”客戶進行保護,確保其在買入某種產品時能夠獲得充分的披露信息。該法規被稱為零售及保險投資產品組合法規(MiFID II指令2014/65/EU)或PRIIP,其覆蓋了所有應付給客戶的金額會受參考值或一種或多種并非由該等零售投資者直接買入之資產的業績表現影響而波動的投資。常見列子包括期權、期貨、差價合約、ETF、ETN和其它結搆性產品。
值得注意的是,經紀商不得允許零售客戶購買PRIIP覆蓋的產品,除非該產品的發行機搆已經備好了要求的披露文件讓經紀商提供給客戶。這種披露文件被稱為關鍵信息文件(“KID”),包括產品描述、成本、風險回報情況及可能的業績情境等信息。美國客戶不受PRIIP影響,因此,某些美國掛牌ETF的發行機搆通常不會創建關鍵信息文件。這就意味著,歐洲經濟區(“EEA”)的零售客戶可能無法購買此類產品。
客戶分類
IBKR默認將所有個人客戶分類為“零售”客戶,因為這樣可以給與客戶MiFID提供的最廣泛的保護。被分類為“專業”客戶的客戶無法享受“零售”客戶級別的保護,但同時也不需要受KID文件要求的限制。根據MiFID II的定義,“專業”客戶包括受監管的實體、大型客戶和要求被重新分類為“選擇性專業客戶”并且在知識、經驗和財務實力方面滿足MiFID II要求的個人。
IB提供了線上程序可供“零售”客戶申請將其分類更改為“專業”。重新分類的資格要求以及申請重新分類的步驟,請參見KB3298,如果要直接申請更改分類,可通過客戶端/賬戶管理中的相關問卷進行。
BACKGROUND
In 2018, an EU regulation, intended to protect “Retail” clients by ensuring that they are provided with adequate disclosure when purchasing certain products took effect. This disclosure document is referred to as a Key Information Document, or KID, and it contains information such as product description, cost, risk-reward profile and possible performance scenarios.
This regulation is known as the Packaged Retail and Insurance-based Investment Product Regulation (MiFID II, Directive 2014/65/EU), or PRIIPs, and it covers any investment where the amount payable to the client fluctuates because of exposure to reference values or to the performance of one or more assets not directly purchased by such retail investor. Common examples of such products include options, futures, CFDs, ETFs, ETNs and other structured products.
The UK Financial Conduct Authority (FCA) has equivalent requirements for UK residents.
It’s important to note that a broker cannot allow a Retail client to purchase a product covered by PRIIPs unless the issuer of that product has prepared the required disclosure document for the broker to provide to the client. U.S. clients are not impacted by PRIIPs, so the issuers of U.S. listed ETFs do not as a rule create KIDs. This means that EEA and UK Retail clients may not purchase the product. Clients nevertheless have several options:
CLIENT CATEGORISATION
We categorize all individual clients as “Retail” by default as this affords clients the broadest level of protection afforded by MiFID. Client who are categorised as “Professional” do not receive the same level of protection as “Retail” but are not subject to the KIDs requirement. As defined under MiFID II rules, “Professional” clients include regulated entities, large clients and individuals who have asked to be re-categorised as “elective professional clients” and meet the MiFID II requirements based on their knowledge, experience and financial capability.
We provide an online step-by-step process that allows “Retail” to request that their categorisation be changed to “Professional". The qualifications for re-categorisation along with the steps for requesting that one’s categorisation be considered are outlined in KB3298 or, to directly apply for a change in categorisation, the questionnaire is available in the Client Portal/Account Management.
簡介
2019年1月30日,iPath S&P 500 VIX短期期貨(VXX)和中期期貨(VXZ)交易所交易票據(ETN)即將到期。考慮到VXX和VXZ即將到期,其發行機搆巴克萊銀行發行了iPath“B系列”的S&P 500 VIX短期期貨(VXXB)和中期期貨(VXZB)交易所交易票據,於2018年1月開始交易,并將於2048年到期。
持有與即將到期的ETN及/或其衍生產品相關之頭寸的客戶應熟悉事件的時間安排、可做的選擇以及相關風險和保證金影響。請注意,如不釆取相應行動,或釆取行動時不考慮保證金影響,可能會將您的賬戶置於不符合保證金要求的境地,從而導致強制清算。
下方常見問題提供了與該事件相關的背景信息。
常見問題解答
問:VXX和VXZ交易所交易票據何時到期?答:VXX和VXZ將在2019年1月30日開槃時到期并摘牌。問:VXX和VXZ的最后交易日是哪天?
答:2019年1月29日將會是該等即將到期之ETN的最后交易日和最后估值日。
問:到期后VXX和VXZ會如何處理?
答:發行機搆為VXX和VXZ的持有者提供了選擇,即贖回票據兌換現金或以1:1的比例兌換對應的“B系列”票據。或者,該等票據持有者還可選擇在2019年1月30日前平倉并將頭寸替換成二級市場上對應的“B系列”票據。
問:如果贖回兌現該等即將到期的票據,可以獲得多少現金?
答:如選擇兌現票據,您每張票據可獲得的現金將等於2019年1月29日(即最后估值日)所適用的收槃指示性價值。
問:贖回交易何時會記入我的賬戶?
答:贖回交易,無論是兌現還是兌換“B系列”票據,都會在2019年1月29日收槃后處理,并會於2019年1月30日開槃前記入您的賬戶。
問:如何將我的贖回決定告知IBKR?
答:我們會通過消息中心和電子郵箱向多頭持有即將到期之頭寸的客戶發送通知,屆時會開放選擇窗口。通知會詳細說明如何通過客戶端/賬戶管理內的自願公司行動工具提交選擇。
問:是否可以選擇提早贖回?
答:客戶可以在到期前提早贖回票據兌換“B系列”票據或現金(即提前贖回),但需付$500.00美元費用。到期贖回沒有費用。
問:選擇決定是否可以撤銷?
答:提前贖回選擇不可撤銷。到期贖回選擇在選擇窗口關閉前均可撤銷。
問:IBKR是否支持現金和“B系列”票據結合的方式贖回?答:不支持。客戶只可在全現金和全“B系列”票據之間選擇一個。問:如果在選擇窗口關閉前沒有提供選擇決定會怎么樣?
答:如果您決定不釆取行動或未能在截止時間前釆取行動,到期頭寸將兌換為現金。
問:如果在最后交易日前持有即將到期票據的空頭頭寸會怎么樣?
答:如果在最后交易日前持有即將到期票據的空頭頭寸,出借方有權平倉您的空頭頭寸,強制您交付現金或對應的“B系列”票據。如果您沒有足夠數量的“B系列”票據多頭頭寸可供交付,則您會被分配一個空頭頭寸,如果無法借到該ETN,您將面臨強制平倉。
問:如果在最后交易日后持有即將到期票據的空頭頭寸會怎么樣?
答:如果在最后交易日后持有即將到期票據的空頭頭寸,則您必須交付現金。
問:與該事件相關的保證金影響有哪些?
答:在投資組合保證金賬戶中持有即將到期ETN的客戶需要特別注意票據到期和贖回選擇對其保證金要求的影響。盡管VXX、VXZ及其相關衍生品列入了美國貨幣監理署(OCC)的客戶投資組合保證金文件,IB對這些產品提供投資組合保證金交易,但其對應的“B系列”票據并沒有列入OCC的投資組合保證金文件,因此IBKR不會對該等產品提供投資組合保證金交易。這些“B系列”ETN和衍生品將根據Reg.T規定計算保證金要求。
因此,在當前投資組合保證金框架下支持的VXX和其它短期波動率產品(如VIXY、VIIX、UVXY、TVIX和SVXY)之間的保證金對銷將不會適用於VXXB。同樣,當前支持的VXZ和其它中期波動率產品(如VIXM和ZIV)之間的保證金對銷也不會適用於VXZB。此外,由於Reg. T只對一部分期權策略提供保證金減免,Reg.T保證金框架下持有包含VXXB或VXZB的復合期權頭寸的客戶其保證金要求可能會高於投資組合保證金框架下對應VXX或VXZ頭寸的保證金要求。
客戶可通過在風險漫游中創建“What-if“投資組合來模擬VXX和VXZ到期的影響以及相關贖回選擇。
注:如果贖回即將到期的ETN將其兌換成對應的“B系列”票據會導致賬戶保證金不足,IBKR有權禁止該等贖回,并強制進行現金贖回。
斯圖加特交易所(Boerse Stuttgart)和明訊銀行(Clearstream Banking)宣布其將不再對主營業務與大麻及其它毒品直接或間接相關的證券提供服務。 因此,該等證券將不會再於斯圖加特(SWB)或法蘭克福(FWB)證券交易所交易。自2018年9月19日收槃開始,IBKR將釆取以下行動:
下方表格列出了斯圖加特交易所和明訊銀行截至2018年8月7日公布的受影響證券。該表格還標記了受影響證券是否能夠轉至美國掛牌市場。注意,清算所已聲明該列表可能尚不完整,建議客戶檢查其各自網站了解最新信息。
ISIN | 名稱 | 交易所 | 是否可轉至美國? | 美國代碼 |
CA00258G1037 |
ABATTIS BIOCEUTICALS CORP |
FWB2 | 是 |
ATTBF |
CA05156X1087 |
AURORA CANNABIS INC |
FWB2, SWB2 | 是 |
ACBFF |
CA37956B1013 |
GLOBAL CANNABIS APPLICATIONS |
FWB2 | 是 |
FUAPF |
US3988451072 |
GROOVE BOTANICALS INC |
FWB | 是 |
GRVE |
US45408X3089 |
INDIA GLOBALIZATION CAPITAL |
FWB2, SWB2 | 是 |
ICG |
CA4576371062 |
INMED PHARMACEUTICALS INC |
FWB2 | 是 |
IMLFF |
CA53224Y1043 |
LIFESTYLE DELIVERY SYSTEMS I |
FWB2, SWB2 | 是 |
LDSYF |
CA56575M1086 |
MARAPHARM VENTURES INC |
FWB2, SWB2 | 是 |
MRPHF |
CA5768081096 |
MATICA ENTERPRISES INC |
FWB2, SWB2 | 是 |
MQPXF |
CA62987D1087 |
NAMASTE TECHNOLOGIES INC |
FWB2, SWB2 | 是 |
NXTTF |
CA63902L1004 |
NATURALLY SPLENDID ENT LTD |
FWB2, SWB2 | 是 |
NSPDF |
CA88166Y1007 |
TETRA BIO-PHARMA INC |
FWB2 | 是 |
TBPMF |
CA92347A1066 |
VERITAS PHARMA INC |
FWB2 | 是 |
VRTHF |
CA1377991023 |
CANNTAB THERAPEUTICS LTD |
FWB2 | 否 | |
CA74737N1042 |
QUADRON CANNATECH CORP |
FWB2 | 否 | |
CA84730M1023 |
SPEAKEASY CANNABIS CLUB LTD |
FWB2, SWB2 | 否 | |
CA86860J1066 |
SUPREME CANNABIS CO INC/THE |
FWB2 | 否 | |
CA92858L2021 |
VODIS PHARMACEUTICALS INC |
FWB2 | 否 |
重要注意事項:
Boerse Stuttgart and Clearstream Banking have announced that they will no longer provide services for issues whose main business is connected directly or indirectly to cannabis and other narcotics products. Consequently, those securities will no longer trade on the Stuttgart (SWB) or Frankfurt (FWB) stock exchanges. Effective as of the 19 September 2018 close, IBKR will take the following actions:
Outlined in the table below are impacted issues as announced by the Boerse Stuttgart and Clearstream Banking as of 7 August 2018. This table includes a notation as to whether the impacted issue is eligible for transfer to a U.S. listing. Note that the clearinghouses have indicated that this list may not yet be complete and clients are advised to review their respective websites for the most current information.
ISIN | NAME | EXCHANGE | U.S. TRANSFER ELIGIBLE? | U.S. SYMBOL |
CA00258G1037 |
ABATTIS BIOCEUTICALS CORP |
FWB2 | YES |
ATTBF |
CA05156X1087 |
AURORA CANNABIS INC |
FWB2, SWB2 | YES |
ACBFF |
CA37956B1013 |
GLOBAL CANNABIS APPLICATIONS |
FWB2 | YES |
FUAPF |
US3988451072 |
GROOVE BOTANICALS INC |
FWB | YES |
GRVE |
US45408X3089 |
INDIA GLOBALIZATION CAPITAL |
FWB2, SWB2 | YES |
ICG |
CA4576371062 |
INMED PHARMACEUTICALS INC |
FWB2 | YES |
IMLFF |
CA53224Y1043 |
LIFESTYLE DELIVERY SYSTEMS I |
FWB2, SWB2 | YES |
LDSYF |
CA56575M1086 |
MARAPHARM VENTURES INC |
FWB2, SWB2 | YES |
MRPHF |
CA5768081096 |
MATICA ENTERPRISES INC |
FWB2, SWB2 | YES |
MQPXF |
CA62987D1087 |
NAMASTE TECHNOLOGIES INC |
FWB2, SWB2 | YES |
NXTTF |
CA63902L1004 |
NATURALLY SPLENDID ENT LTD |
FWB2, SWB2 | YES |
NSPDF |
CA88166Y1007 |
TETRA BIO-PHARMA INC |
FWB2 | YES |
TBPMF |
CA92347A1066 |
VERITAS PHARMA INC |
FWB2 | YES |
VRTHF |
CA1377991023 |
CANNTAB THERAPEUTICS LTD |
FWB2 | NO | |
CA74737N1042 |
QUADRON CANNATECH CORP |
FWB2 | NO | |
CA84730M1023 |
SPEAKEASY CANNABIS CLUB LTD |
FWB2, SWB2 | NO | |
CA86860J1066 |
SUPREME CANNABIS CO INC/THE |
FWB2 | NO | |
CA92858L2021 |
VODIS PHARMACEUTICALS INC |
FWB2 | NO |
IMPORTANT NOTES: